We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Contact Aspiration Equals Stent Retriever for Acute Stroke Care

By HospiMedica International staff writers
Posted on 07 Mar 2017
The direct aspiration, first pass technique (ADAPT) for clearing large-vessel ischemic strokes is as safe and successful for reperfusion as a stent retriever, according to a new study.

Researchers at Foch Hospital, Lille University of Science and Technology, and other institutions conducted the prospective ADAPT versus StEnt Retriever (ASTER) study to compare the two strategies for treating patients with ischemic anterior circulation stroke secondary to large vessel occlusion (LVO). More...
Patients who met criteria on imaging were randomized to either direct contact aspiration (192 patients), or to mechanical thrombectomy with a stent retriever (189 patients) as first-line treatment, with a switch to other therapy allowed after three failed attempts.

The primary outcome was successful recanalization, with secondary outcomes including initial successful use of the assigned treatment technique, overall procedural times, complications, and modified Rankin Scale (mRS) at three month. The results showed that the rate of successful recanalization at the end of the treatment was 85.4% with ADAPT using the Penumbra stroke system aspiration catheter, compared to 83.1% with stent retriever as the first-line strategy.

In addition, 63% of the patients treated with ADAPT achieved the three month secondary endpoints, compared to 67.7% of the patients treated with stent retrievers. All safety endpoints, including new embolization or infarct, arterial perforation, arterial dissection, vasospasm, and intracranial or subarachnoid hemorrhage were similar between treatment strategies. The study was presented at the International Stroke Conference, held during February 2017 in Houston (TX, USA).

“There are no significant difference in revascularization rate and safety using either thrombectomy technique with Penumbra aspiration and stent retrievers for acute ischemic stroke patients with large vessel occlusions," said lead author Bertrand Lapergue, MD, PhD, of the stroke center at Foch Hospital. “The broad eligibility criteria achieved make the ASTER results generalizable to the majority of stroke patients with large vessel occlusions.”

Stent retrievers are deployed in an occluded vessel and are temporarily expanded into the body of a thrombus in order to recanalize the vessel, allowing for reperfusion of ischemic sites and causing the thrombus to be partially entangled within the stent. Thrombectomy is then performed by retracting the stent.


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.